MBX · MBX Biosciences, Inc. · Documents
Market Cap
$2.84B
Shares
48.16M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-27 | — | |
| 8-K | 2026-08-06 | — | |
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-07-13 | 2026-07-09 | |
| 8-K | 2026-06-12 | — | |
| Investor Event Transcript | 2026-06-12 | 2026-06-30 | |
| 8-K | 2026-06-05 | 2026-06-04 | |
| Investor Event Transcript | 2026-06-03 | 2026-06-30 | |
| 8-K | 2026-05-11 | — | |
| 8-K | 2026-05-07 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| DEF 14A | 2026-04-22 | — | |
| 8-K | 2026-03-12 | — | |
| 10-K | 2026-03-12 | 2025-12-31 | |
| Investor Event Transcript | 2026-03-11 | 2026-03-31 | |
| 8-K | 2026-03-09 | — | |
| 8-K | 2026-02-27 | 2026-02-24 | |
| 8-K | 2026-02-05 | 2026-02-04 | |
| 8-K | 2026-01-22 | 2026-01-20 | |
| 8-K | 2026-01-12 | 2026-01-11 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | 2025-10-31 | |
| Investor Event Transcript | 2025-09-30 | — | |
| 8-K | 2025-09-26 | 2025-09-24 | |
| 8-K | 2025-09-22 | — | |
| 8-K | 2025-09-04 | — | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-06-16 | — | |
| 8-K | 2025-06-09 | — | |
| 8-K | 2025-06-06 | 2025-06-05 | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| 8-K | 2025-05-12 | — | |
| DEF 14A | 2025-04-23 | 2025-04-22 | |
| 8-K | 2025-04-07 | — | |
| 8-K | 2025-03-17 | — | |
| 10-K | 2025-03-17 | 2024-12-31 | |
| 8-K | 2025-01-07 | — | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-09-16 | — |
Showing 1–41 of 41 filings
Key facts
CIK
1776111
CUSIP
55287L101
13F (30d)
101 filings
101 filers
Visit website
Investor relations